RSTN COVID手部研究:COVID-19大流行期间英国与欧洲的手部创伤
重建外科试验网络在2020年COVID-19第一波期间开展服务评估,纳入35个手外科单元的2540例手部创伤患者,比较疫情期间与疫情前临床医生原本会采取的处理方式。除屈肌腱损伤处理不变外,非手术治疗增加3%至7%,顾问分诊翻倍,see-and-treat模式增加22%,小手术室和诊室手术分别增加13%和10%,WALANT、可吸收缝线和远程随访分别增加16%、24%和11%至25%,报告的30天并发症率为3.2%,手术部位感染率为1.8%。
要点
- 35个手外科单元2540例手部创伤患者中,除屈肌腱损伤外非手术治疗增加3%至7%。
- 顾问分诊翻倍,see-and-treat模式增加22%,小手术室和诊室手术分别增加13%和10%。
- WALANT、可吸收缝线和远程随访分别增加16%、24%和11%至25%,30天并发症率3.2%。
核心结论
- 大流行促使手部创伤诊疗在多方面快速转变,增加手术室外操作、局部麻醉和非手术治疗,且并发症率未增加。
- 作者认为需进一步研究评估这些变化的临床与成本效益,以确保COVID-19成为现代、循证且环境可持续的手部创伤服务催化剂。
研究设计与样本
- 重建外科试验网络(Reconstructive Surgery Trials Network)在2020年COVID-19第一波期间开展的服务评估。
- 收集COVID-19大流行期间手部损伤处理数据,并与临床医生原本会采取的处理方式比较。
- 共纳入35个手外科单元的2540例手部创伤患者。
主要发现
- 除屈肌腱损伤处理不变外,非手术治疗增加3%至7%。
- 顾问分诊病例翻倍,see-and-treat模式增加22%。
- 小手术室使用增加13%,诊室手术增加10%。
- WALANT使用增加16%,可吸收缝线使用增加24%,远程随访增加11%至25%。
- 报告的30天并发症率为3.2%,手术部位感染率为1.8%。
临床怎么用
- 作者认为需进一步研究评估这些变化的临床与成本效益,以确保COVID-19成为现代、循证且环境可持续的手部创伤服务催化剂。
局限性
- 作者指出需进一步研究评估这些变化的临床与成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic rapidly impacted the delivery of hand surgery services throughout the UK and Europe; from triage to treatment. Our aim was to assess the impact on management of common hand trauma injuries to inform future service delivery and research. The Reconstructive Surgery Trials Network led a service evaluation during the first wave of COVID-19 in 2020. Data was collected on hand injury management during the COVID-19 pandemic and was compared to the management clinicians would have delivered prior. Across 35 hand surgery units, 2540 patients with hand trauma were included. There was an increase of between 3% and 7% in non-operative management of injuries, apart from flexor tendon injuries where management remained unchanged. Cases triaged by a consultant doubled, with a 22% increase in the see-and-treat model. There was a move to operating in low-resource settings; a 13% increase in the use of minor operating theatres and 10% in clinic rooms. Use of WALANT, absorbable sutures, and remote follow-up also increased by 16%, 24%, and between 11% and 25%, respectively. The reported 30-day complication rate was 3.2%, with a surgical site infection rate of 1.8%. The pandemic led to rapid change in many aspects of hand trauma care. It was the impetus for increased out-of-theatre operating, use of local anaesthetic, and more non-operative management of injuries, without an increase in complication rate. Further research needs to assess the clinical and cost-effectiveness of these changes to ensure that COVID-19 is a catalyst for a modern, evidence-based, and environmentally sustainable delivery of hand trauma services.
引用
- Shaw AV, Holmes D, Jansen V, et al. RSTN COVID Hand: Hand trauma in the United Kingdom and Europe during the COVID-19 pandemic. J Plast Reconstr Aesthet Surg. 2023. PMID: 37354711. doi:10.1016/j.bjps.2023.04.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。